Jodi L Goodrich

US Patent:

7138245, Nov 21, 2006

Filed:

Oct 13, 2004

Appl. No.:

10/965608

Inventors:

Steven R. Binder - Berkeley CA, US
Jodi L. Goodrich - Martinez CA, US
Zara Safarian - Pleasant Hill CA, US

Assignee:

Bio-Rad Laboratories, Inc. - Hercules CA

International Classification:

G01N 33/53

US Classification:

435 71, 435 4, 435 792

Abstract:

Analyses of serum samples for the presence and amount of either of the two subunits of human Factor XIII protein are used as a means of eliminating a significant source of error that arises in the testing of serum and plasma. For serum samples, a negative result of an analysis for the presence of subunit a is a means of verifying that a sample is indeed serum, while a negative or positive result for subunit a serves to distinguish serum (negative) from plasma (positive). A positive result for the presence of subunit b is a means of verifying that the sample is either serum or plasma and not any other biological fluid. A quantitative analysis of subunit b is a means of verifying that the sample is of the intended volume rather than having been reduced in volume due to improper sampling. A quantitative analysis of subunit b is also a means of verifying the dilution of a sample of either serum or plasma.

US Patent:

7141362, Nov 28, 2006

Filed:

Oct 14, 2004

Appl. No.:

10/966650

Inventors:

Steven R. Binder - Berkeley CA, US
Jodi L. Goodrich - Martinez CA, US
Zara Safarian - Pleasant Hill CA, US

Assignee:

Bio-Rad Laboratories, Inc. - Hercules CA

International Classification:

G01N 33/53

US Classification:

435 21, 435 4, 435 792

Abstract:

Analyses of serum samples for the presence and amount of either of the two subunits of human Factor XIII protein are used as a means of eliminating a significant source of error that arises in the testing of serum and plasma. For serum samples, a negative result of an analysis for the presence of subunit a is a means of verifying that a sample is indeed serum, while a negative or positive result for subunit a serves to distinguish serum (negative) from plasma (positive). A positive result for the presence of subunit b is a means of verifying that the sample is either serum or plasma and not any other biological fluid. A quantitative analysis of subunit b is a means of verifying that the sample is of the intended volume rather than having been reduced in volume due to improper sampling. A quantitative analysis of subunit b is also a means of verifying the dilution of a sample of either serum or plasma.

US Patent:

20030082828, May 1, 2003

Filed:

May 31, 2001

Appl. No.:

09/872639

Inventors:

Steven Binder - Berkeley CA, US
Jodi Goodrich - Martinez CA, US
Zara Safarian - Pleasant Hill CA, US

International Classification:

G01N033/53
G01N033/542
G01N033/543

US Classification:

436/518000, 435/007900

Abstract:

Analyses of serum samples for the presence and amount of either of the two subunits of human Factor XIII protein are used as a means of eliminating a significant source of error that arises in the testing of serum and plasma. For serum samples, a negative result of an analysis for the presence of subunit a is a means of verifying that a sample is indeed serum, while a negative or positive result for subunit a serves to distinguish serum (negative) from plasma (positive). A positive result for the presence of subunit b is a means of verifying that the sample is either serum or plasma and not any other biological fluid. A quantitative analysis of subunit b is a means of verifying that the sample is of the intended volume rather than having been reduced in volume due to improper sampling. A quantitative analysis of subunit b is also a means of verifying the dilution of a sample of either serum or plasma.

US Patent:

20030113801, Jun 19, 2003

Filed:

Oct 1, 2002

Appl. No.:

10/263436

Inventors:

Steven Binder - Berkeley CA, US
Jodi Goodrich - Martinez CA, US
Zara Safarian - Pleasant Hill CA, US

Assignee:

Bio-Rad Laboratories, Inc. - Hercules CA

International Classification:

G01N033/53

US Classification:

435/007100

Abstract:

Analyses of serum samples for the presence and amount of either of the two subunits of human Factor XIII protein are used as a means of eliminating a significant source of error that arises in the testing of serum and plasma. For serum samples, a negative result of an analysis for the presence of subunit a is a means of verifying that a sample is indeed serum, while a negative or positive result for subunit a serves to distinguish serum (negative) from plasma (positive). A positive result for the presence of subunit b is a means of verifying that the sample is either serum or plasma and not any other biological fluid. A quantitative analysis of subunit b is a means of verifying that the sample is of the intended volume rather than having been reduced in volume due to improper sampling. A quantitative analysis of subunit b is also a means of verifying the dilution of a sample of either serum or plasma.